Enveric Biosciences reports 2022 annual meeting results; all proposals pass

Enveric Biosciences, Inc.

Annual meeting quorum: 856,447 shares (41.2% of outstanding); all seven director nominees elected, with Joseph Tucker receiving 228,825 votes for.
Advisory vote on named executive officer compensation passed with 178,176 for, 68,125 against, 1,771 abstain.
Ratification of Marcum LLP as independent auditor approved with 826,728 for, 27,656 against, 2,063 abstain.
Broker non-votes totaled 608,375 on director election and advisory proposals.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Enveric Biosciences, Inc. shareholders approved Election of seven directors at the 2022-10-28 meeting.

Proposal: director election
Outcome: passed
Meeting: 2022-10-28

Exact text from the filing

Nominee For Withheld Broker Non-Votes George Kegler 138,269 109,803 608,375

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Enveric Biosciences, Inc. shareholders approved Non-binding advisory vote to approve the compensation of the Company’s named executive officers at the 2022-10-28 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2022-10-28

Exact text from the filing

For Against Abstain Broker Non-Votes 178,176 68,125 1,771 608,375

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Enveric Biosciences, Inc. shareholders approved Ratification of the selection and appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 at the 2022-10-28 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2022-10-28

Exact text from the filing

For Against Abstain 826,728 27,656 2,063

View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Enveric Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-029856

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.